IMNM
Immunome IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.64B
P/E Ratio
—
EPS
$-2.49
Beta
2.12
52W High
$27.65
52W Low
$7.15
50-Day MA
$21.93
200-Day MA
$17.69
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Immunome Inc
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapies for oncology and infectious diseases. The company is headquartered in Exton, Pennsylvania.
Fundamentals
| Revenue (TTM) | $6.94M |
| Gross Profit (TTM) | $-170.34M |
| EBITDA | $-211.65M |
| Operating Margin | -3085.00% |
| Return on Equity | -52.10% |
| Return on Assets | -29.00% |
| Revenue/Share (TTM) | $0.08 |
| Book Value | $5.61 |
| Price-to-Book | 4.06 |
| Price-to-Sales (TTM) | 380.65 |
| EV/Revenue | 277.27 |
| EV/EBITDA | -0.72 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $113.25M |
| Float | $94.33M |
| % Insiders | 7.32% |
| % Institutions | 103.60% |
Historical Volatility
HV 10-Day
32.61%
HV 20-Day
40.08%
HV 30-Day
53.50%
HV 60-Day
49.52%
HV Rank
9.5%
Volatility is currently contracting
Analyst Ratings
Consensus ($35.17 target)
2
Strong Buy12
BuyMore HEALTHCARE Stocks
Data last updated: 5/5/2026